Blog

South West nos

[Stock idea]: South West Pinnacle – From drilling for others to owning a coal mine

South West Pinnacle drills for coal, minerals, oil, gas and groundwater for clients like Reliance, Hindustan Zinc and ONGC. Its Q1 profit rose 287%, and its order book has hit a record ₹761 cr, more than 3x last year’s revenue. The other side: Two contracts make up about 60% of that order book. And the company is preparing to fund a coal mine and an Oman mining block. Our notes from the presentation and the concall are below, but before…

Read More
Alivus numbers Q1

[Stock idea]: Alivus Lifesciences – Its biggest customer cut orders by 53%. Profit still rose 32%

Alivus Life Sciences (formerly Glenmark Life Sciences) saw sales to its largest customer, former parent Glenmark Pharmaceuticals, fall 53% in Q1. Total revenue still grew 6%, and profit grew 32%. The rest of the business grew 26.5%, mostly on volume, and margins hit a record. But to meet its own full-year guidance, Alivus now needs the best three quarters in its history. Our notes from the presentation and the concall are below, but before that: Spread the Word: If you…

Read More
DC infotech FY 26 nos

[Stock idea]: DC Infotech – From box-mover to AI infrastructure: DC Infotech’s ₹1,000 cr plan

DC Infotech grew revenue 33% to ₹737 cr in FY26 and profit 46%, and management says it is on track for ₹1,000 cr. It now presents itself as an AI-infrastructure and cybersecurity company rather than a hardware distributor. The balance sheet tells a second story. Receivables rose 61% and inventory 62%, so roughly ₹74 cr went into working capital, more than three times the year’s profit. Our notes from the presentation and the concall are below, but before that: Spread…

Read More
Prevest FY 26 nos

[Stock idea]: Prevest Denpro – This dental maker could reach ₹125 cr revenue without building a new factory

Prevest Denpro makes dental fillings, root-canal materials and 3D-printing resins in Jammu, and earns an EBITDA margin of nearly 40%. Its main plant is still running at only about two-thirds of capacity. The question is growth. Revenue grew 14% in FY26, Q4 grew under 3%, and an investor on the call asked management directly why growth has slowed. Our notes from the presentation and the concall are below, but before that: Spread the Word: If you think our stock recommendations…

Read More